ASTRAZENECA PROVIDES UPDATE ON PRODUCT PIPELINE STRENGTHENING

A A

AstraZeneca sought to reassure investors this week by providing an update on progress made in strengthening its product pipeline, a worry for industry analysts who believe its existing products cannot underpin earnings growth for much longer.
DrugResearcher.com